Methods
The investigational product NR-INF-02, an extract from
rhizome of Curcuma longa Linn., developed and registered
as TurmacinTM by Natural Remedies Pvt. Ltd, Bangalore,
India was used as a trial medication. This was supplied as
oral gelatin capsules each 500 mg of active NR-INF-02
containing 12.6 % w/w polysaccharides as determined by
high pressure liquid chromatography (HPLC) described by
Gomis et al. (2001).